Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Company to begin trial with dual-optic accommodative lens ➤ Phase 2 study to begin for immunoglobulin drops for dry eye ➤ Long-term durability of TED treatment demonstrated ➤ Positive Phase 1/2 data from study evaluating X-linked retinoschisis ➤ Eye drop recall ➤ ASCRS news and events
➤ Positive update from Phase 2 study evaluating oligonucleotide for AMD and DME ➤ 18-month data presented on novel drug delivery platform ➤ Phase 1/2a trial results for intravitreal injection for treatment of glaucoma ➤ Advancing AI to facilitate detection and improve management of ocular disease ➤ Fast Track designation granted for neuropathic corneal pain ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy ➤ ASCRS news and events
➤ Positive results in Phase 1 trial for geographic atrophy cell-based therapy ➤ Enrollment complete for Phase 3 DME drop trials ➤ Enrollment complete in study for hydrogel retinal sealant ➤ First patient dosed in Phase 2 trial studying oral diabetic retinopathy therapy ➤ Regenerative Medicine Advanced Therapy designation granted to gene therapy candidate for X-linked retinoschisis ➤ ASCRS news and events
➤ NDA submitted to the FDA for presbyopia drop ➤ FDA issues complete response letter to dry eye NDA ➤ FDA accepts BLA resubmission for bevacizumab to treat wet AMD ➤ One-month results in Phase 1/2 trial for treating Leber congenital amaurosis in a pediatric patient ➤ ASCRS news and events
➤ Long-term data on treatment for neuropathic corneal pain ➤ European agency issues positive opinion for low-dose atropine formulation ➤ Study: semaglutide use associated with increased risk of NAION ➤ Company news ➤ ASCRS news and events
➤ Voluntary IOL recall ➤ Phase 4 study assesses patient-reported outcomes of dry eye drop ➤ Study: synthetic opsin restores vision in cases of severe retinal degeneration ➤ Phase 3 endpoints not met in trial evaluating wet AMD treatment ➤ Merger news ➤ ASCRS news and events
➤ Study: long-term efficacy of uveoscleral outflow enhancement for glaucoma ➤ FDA grants expanded indication for fluocinolone acetonide intravitreal implant ➤ First patient dosed in Phase 1/2 gene therapy trial targeting Stargardt disease ➤ Merger complete ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.